176 related articles for article (PubMed ID: 21321285)
1. Acid-suppressive medication use and the risk for nosocomial gastrointestinal tract bleeding.
Herzig SJ; Vaughn BP; Howell MD; Ngo LH; Marcantonio ER
Arch Intern Med; 2011 Jun; 171(11):991-7. PubMed ID: 21321285
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for nosocomial gastrointestinal bleeding and use of acid-suppressive medication in non-critically ill patients.
Herzig SJ; Rothberg MB; Feinbloom DB; Howell MD; Ho KK; Ngo LH; Marcantonio ER
J Gen Intern Med; 2013 May; 28(5):683-90. PubMed ID: 23292499
[TBL] [Abstract][Full Text] [Related]
3. Acid-suppressive medication use and the risk for hospital-acquired pneumonia.
Herzig SJ; Howell MD; Ngo LH; Marcantonio ER
JAMA; 2009 May; 301(20):2120-8. PubMed ID: 19470989
[TBL] [Abstract][Full Text] [Related]
4. Acid-suppressive medication use in acute stroke and hospital-acquired pneumonia.
Herzig SJ; Doughty C; Lahoti S; Marchina S; Sanan N; Feng W; Kumar S
Ann Neurol; 2014 Nov; 76(5):712-8. PubMed ID: 25164323
[TBL] [Abstract][Full Text] [Related]
5. Histamine-2-receptor antagonist administration and gastrointestinal bleeding when used for stress ulcer prophylaxis in patients with severe sepsis or septic shock.
Barletta JF
Ann Pharmacother; 2014 Oct; 48(10):1276-81. PubMed ID: 24982312
[TBL] [Abstract][Full Text] [Related]
6. Acid Suppressive Therapy for Stress Ulcer Prophylaxis in Noncritically Ill Patients.
Hong MT; Monye LC; Seifert CF
Ann Pharmacother; 2015 Sep; 49(9):1004-8. PubMed ID: 26139638
[TBL] [Abstract][Full Text] [Related]
7. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit.
MacLaren R; Reynolds PM; Allen RR
JAMA Intern Med; 2014 Apr; 174(4):564-74. PubMed ID: 24535015
[TBL] [Abstract][Full Text] [Related]
8. Acid suppressive therapy in noncritically ill patients.
Barletta JF; El-Ibiary SY
Arch Intern Med; 2011 Nov; 171(20):1861; author reply 1861-2. PubMed ID: 22083578
[No Abstract] [Full Text] [Related]
9. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.
Howell MD; Novack V; Grgurich P; Soulliard D; Novack L; Pencina M; Talmor D
Arch Intern Med; 2010 May; 170(9):784-90. PubMed ID: 20458086
[TBL] [Abstract][Full Text] [Related]
10. Gastric Acid Suppressant Prophylaxis in Pediatric Intensive Care: Current Practice as Reflected in a Large Administrative Database.
Costarino AT; Dai D; Feng R; Feudtner C; Guevara JP
Pediatr Crit Care Med; 2015 Sep; 16(7):605-12. PubMed ID: 25901549
[TBL] [Abstract][Full Text] [Related]
11. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis.
Alhazzani W; Alenezi F; Jaeschke RZ; Moayyedi P; Cook DJ
Crit Care Med; 2013 Mar; 41(3):693-705. PubMed ID: 23318494
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and outcome of gastrointestinal bleeding and use of acid suppressants in acutely ill adult intensive care patients.
Krag M; Perner A; Wetterslev J; Wise MP; Borthwick M; Bendel S; McArthur C; Cook D; Nielsen N; Pelosi P; Keus F; Guttormsen AB; Moller AD; Møller MH;
Intensive Care Med; 2015 May; 41(5):833-45. PubMed ID: 25860444
[TBL] [Abstract][Full Text] [Related]
13. Histamine H2-Blocker and Proton Pump Inhibitor Use and the Risk of Pneumonia in Acute Stroke: A Retrospective Analysis on Susceptible Patients.
Arai N; Nakamizo T; Ihara H; Koide T; Nakamura A; Tabuse M; Miyazaki H
PLoS One; 2017; 12(1):e0169300. PubMed ID: 28085910
[TBL] [Abstract][Full Text] [Related]
14. Hospital-acquired gastrointestinal bleeding outside the critical care unit: risk factors, role of acid suppression, and endoscopy findings.
Qadeer MA; Richter JE; Brotman DJ
J Hosp Med; 2006 Jan; 1(1):13-20. PubMed ID: 17219466
[TBL] [Abstract][Full Text] [Related]
15. Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrhea.
Buendgens L; Bruensing J; Matthes M; Dückers H; Luedde T; Trautwein C; Tacke F; Koch A
J Crit Care; 2014 Aug; 29(4):696.e11-5. PubMed ID: 24674763
[TBL] [Abstract][Full Text] [Related]
16. Incidence and risk factors of gastrointestinal bleeding in patients on low-dose aspirin therapy after percutaneous coronary intervention in Japan.
Nadatani Y; Watanabe T; Tanigawa T; Sogawa M; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Yoshiyama M; Arakawa T
Scand J Gastroenterol; 2013 Mar; 48(3):320-5. PubMed ID: 23298342
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
Lin PC; Chang CH; Hsu PI; Tseng PL; Huang YB
Crit Care Med; 2010 Apr; 38(4):1197-205. PubMed ID: 20173630
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and safety of acid suppressants for gastrointestinal bleeding prophylaxis in cardiac care unit patients.
Chen C; Liu H; Duan R; Wang F; Duan L
J Gastroenterol Hepatol; 2021 Aug; 36(8):2131-2140. PubMed ID: 33586808
[TBL] [Abstract][Full Text] [Related]
19. Stress ulcer prophylaxis with proton pump inhibitors or histamine 2 receptor antagonists in critically ill adults - a meta-analysis of randomized controlled trials with trial sequential analysis.
Zhou X; Fang H; Xu J; Chen P; Hu X; Chen B; Wang H; Hu C; Xu Z
BMC Gastroenterol; 2019 Nov; 19(1):193. PubMed ID: 31752703
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of acid suppressants and other mucoprotective agents in reducing the risk of occult gastrointestinal bleeding in nonsteroidal anti-inflammatory drug users.
Kim TJ; Kim ER; Hong SN; Kim YH; Lee YC; Kim HS; Kim K; Chang DK
Sci Rep; 2019 Aug; 9(1):11696. PubMed ID: 31406189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
